Suppr超能文献

表现为伴有抗磷脂抗体和低ADAMTS-13活性的中风的危及生命的新冠肺炎及治疗性血浆置换的作用:病例系列

Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: A case series.

作者信息

Alharthy Abdulrahman, Faqihi Fahad, Balhamar Abdullah, Memish Ziad A, Karakitsos Dimitrios

机构信息

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

Research and Innovation Center, King Saud Medical City, Riyadh, Saudi Arabia.

出版信息

SAGE Open Med Case Rep. 2020 Oct 8;8:2050313X20964089. doi: 10.1177/2050313X20964089. eCollection 2020.

Abstract

We present a case series of three patients with COVID-19 who were admitted to our intensive care unit due to acute respiratory distress syndrome, brain infarction, pulmonary embolism, and antiphospholipid antibodies. We applied therapeutic plasma exchange on all cases. On intensive care unit admission, all patients had low (<10) Glasgow Coma Scale, and central nervous imaging showed multiple brain infarctions. COVID-19 was confirmed by reverse transcriptase polymerase chain reaction assays. Patients underwent rescue therapeutic plasma exchange using the Spectra Optia Apheresis System (Terumo BCT Inc., USA), which operates with acid-citrate dextrose anticoagulant as per Kidney Disease Improving Global Outcomes 2019 guidelines. A dose of 1.5 plasma volume was used for the first dose and then 1 plasma volume daily for a total of five doses. Plasma was replaced with Octaplas LG (Octapharma AG, USA), which is an artificial fresh frozen plasma product that has undergone viral inactivation by prion reduction technology. We administered ARDS-net/prone positioning ventilation, empiric antiviral treatment, therapeutic anticoagulation, and intensive care unit supportive care. Laboratory tests showed lymphocytopenia; elevated levels of D-dimer, fibrinogen, total bilirubin, C-reactive protein, lactate dehydrogenase, and ferritin; as well as low levels of ADAMTS-13 activity and antibody. Serology tests depicted positive IgM and IgG antiphospholipid antibodies (anti-cardiolipin and anti-β2-glycoprotein I antibodies). No side effects of therapeutic plasma exchange were recorded. After the completion of therapeutic plasma exchange, patients improved clinically and gradually recovered neurologically (after 27-32 days). To conclude, in life-threatening COVID-19, especially when immune dysregulation features such as antiphospholipid antibodies exist, therapeutic plasma exchange could be an effective rescue therapy.

摘要

我们报告了一组3例新冠肺炎患者的病例系列,这些患者因急性呼吸窘迫综合征、脑梗死、肺栓塞和抗磷脂抗体而入住我们的重症监护病房。我们对所有病例均应用了治疗性血浆置换。入住重症监护病房时,所有患者的格拉斯哥昏迷量表评分均较低(<10分),中枢神经影像学检查显示多发脑梗死。通过逆转录聚合酶链反应检测确诊为新冠肺炎。患者使用Spectra Optia血液成分分离系统(美国Terumo BCT公司)进行挽救性治疗性血浆置换,该系统按照2019年改善全球肾脏病预后组织的指南使用枸橼酸葡萄糖抗凝剂。首剂使用1.5个血浆量,之后每天使用1个血浆量,共使用5剂。血浆用Octaplas LG(美国Octapharma公司)置换,Octaplas LG是一种经过朊病毒减少技术进行病毒灭活的人工新鲜冰冻血浆产品。我们给予了ARDSnet/俯卧位通气、经验性抗病毒治疗、治疗性抗凝以及重症监护病房支持治疗。实验室检查显示淋巴细胞减少;D-二聚体、纤维蛋白原、总胆红素、C反应蛋白、乳酸脱氢酶和铁蛋白水平升高;以及ADAMTS-13活性和抗体水平降低。血清学检查显示抗磷脂抗体(抗心磷脂和抗β2糖蛋白I抗体)IgM和IgG阳性。未记录到治疗性血浆置换的副作用。完成治疗性血浆置换后,患者临床症状改善,神经功能逐渐恢复(27 - 32天后)。总之,在危及生命的新冠肺炎中,尤其是存在抗磷脂抗体等免疫失调特征时,治疗性血浆置换可能是一种有效的挽救治疗方法。

相似文献

5
Thrombolysis in severe COVID-19 pneumonia with massive pulmonary embolism.严重 COVID-19 肺炎伴大块肺栓塞的溶栓治疗。
Am J Emerg Med. 2021 Mar;41:261.e1-261.e3. doi: 10.1016/j.ajem.2020.07.068. Epub 2020 Jul 30.

引用本文的文献

2
New Directions in Infection-Associated Ischemic Stroke.感染相关性缺血性卒中的新方向
J Clin Neurol. 2024 Mar;20(2):140-152. doi: 10.3988/jcn.2023.0056. Epub 2024 Feb 5.
4
COVID-19 and antiphospholipid antibodies.COVID-19 与抗磷脂抗体。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101402. doi: 10.1016/j.beha.2022.101402. Epub 2022 Oct 15.
10
Ischemic Stroke: An Underestimated Complication of COVID-19.缺血性中风:一种被低估的新冠并发症。
Aging Dis. 2021 Jun 1;12(3):691-704. doi: 10.14336/AD.2021.0209. eCollection 2021 Jun.

本文引用的文献

2
Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19.COVID-19 中的脆弱内皮细胞和大脑神经化学活动失调。
ACS Chem Neurosci. 2020 Aug 5;11(15):2159-2162. doi: 10.1021/acschemneuro.0c00437. Epub 2020 Jul 27.
5
Extrapulmonary manifestations of COVID-19.COVID-19 的肺外表现。
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
7
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗?
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
9
The unique characteristics of COVID-19 coagulopathy.COVID-19 凝血功能障碍的独特特征。
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验